BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 25, 2002
View Archived Issues
diaDexus and Emory University form cancer collaboration to target Nox-1 enzyme
Read More
Enact reports titanium-based organometallic compounds as anticancer agents
Read More
Epothilones: multimedia presentation of mechanisms of action in Part II of an Integrity Case Study
Read More
Phase III trial of tecadenoson in PSVT meets primary endpoint
Read More
La Jolla set to complete LJP-394 phase III enrollment
Read More
Improved quality of life reported for long-acting risperidone in schizophrenia
Read More
License agreement for Collagenex's IMPACS compounds for aortic aneurysms
Read More
Potential use of a new conjugated estrogen tablet for postmenopausal hot flushes
Read More
Genaera provides Lomucin update in cystic fibrosis and asthma
Read More
Novel macrolide antibiotics covered by Enanta patent
Read More
AstraZeneca presents novel GnRH antagonists for cancer, BPH and uterine myoma
Read More
GlaxoSmithKline licenses Kissei's selective inhibitors of renal glucose transport for diabetes
Read More
CYP1B1-activated prodrugs of antitumor compound identified by U. of London researchers
Read More
Clofarabine enters phase I/II trial in combination with ara-C
Read More
French researchers describe 5-HT4 ligands with potential in GI and other disorders
Read More
Novel antiproliferative agents prepared at Temple University
Read More
New DHFR inhibitors in early development at Melacure
Read More
NCX-4016 IND cleared for phase II
Read More
Rega Institute claims novel antiviral compounds
Read More
GSK and Biovitrum collaborate on 5-HT2C receptor agonists for obesity and other disorders
Read More
Inhibitor of p56lck tyrosine kinase and its use in rheumatoid arthritis
Read More
Interim results from phase II gastric cancer trial of pemtumomab presented
Read More
First potent inhibitors of glutamate racemase with antipneumococcal activity
Read More
Anti-fstZ PNA molecule with activity against Gram-negative bacteria
Read More
Antidiabetic, hypolipidemic and insulin-sensitizing properties described for novel thiazolidinedione
Read More
Baxter submits MAA in E.U. for rAHF-PFM
Read More
Prandin approved as combination therapy with rosiglitazone or pioglitazone for type 2 diabetes
Read More
Amylin withdraws Symlin MAA in E.U. with plans to resubmit
Read More